Israeli Start-Up Developers Innovative Brain Chip Technology for Neurological Disorders
When it comes to medical research, mice are traditionally the go-to animal models due to their rapid breeding cycles and ethical considerations. Utilizing monkeys, whose genetic makeup is more aligned with humans, is often impossible. However, traditional drug development has proven increasingly ineffective in the realm of neurological and psychiatric disorders, with only a five percent success rate in translating preclinical studies to human clinical trials. About 3.4 billion people worldwide—roughly 43.1% of the global population—suffer from these conditions.
New Breakthrough in Drug Development
A research team from the Israeli start-up Itay and Beyond in Tel Aviv has developed groundbreaking technology to tackle these challenges. They have created brain organoids and a three-dimensional “brain on a chip” that enable testing and repurposing of existing drugs, as well as the development of new treatments. This innovative approach holds significant promise for successfully addressing neurological disorders such as autism spectrum disorder (ASD), epilepsy, and schizophrenia.
Understanding Brain Organoids
A brain organoid is a small, three-dimensional tissue culture that mimics the structure and function of specific parts of the human brain. These organoids are grown from pluripotent stem cells and can be maintained for years, providing researchers with a more accurate and adaptable model than traditional animal models.
The Complexity of Neurological Disorders
The brain is a highly complex system composed of diverse tissues, neurons, and glial cells, making it challenging to study and understand, especially in the context of neurodevelopmental disorders such as autism and epilepsy. The breakthrough technology developed by Itay and Beyond offers a more effective method for examining these conditions.
Itay and Beyond’s Partnerships and Collaborations
Collaborations with leading medical institutions in Israel have expedited the development and testing of this innovative technology. At Hadassah-University Medical Center in Jerusalem’s Ein Kerem, Itay and Beyond is conducting research on autism spectrum disorder. Meanwhile, at Schneider Children’s Medical Center in Petah Tikva, the focus is on epilepsy. These partnerships contribute to the advancement of personalized medicine tailored to individual needs.
Focusing on Autism Spectrum Disorder
Dr. Liya Kerem, a pediatrician and endocrinologist with expertise in neurology and psychology, is collaborating with Itay and Beyond to repurpose existing drugs for the treatment of autism. Autism affects one percent of the world’s population, or over 75 million individuals, including both children and adults. It primarily impacts males four times more frequently than females.
The Role of Genes and Environment in ASD
Genetics and environmental factors play crucial roles in the development of ASD. In some cases, genetic markers for autism can be identified in amniotic fluid during prenatal testing, highlighting the potential for early diagnosis and intervention.
Supporting the Pediatric Technological Community
Dr. Shirley Saar, the director of the Innovation Center at Schneider Children’s Medical Center, expressed her enthusiasm for supporting Itay and Beyond. She stated, “We are pleased to support Itay and Beyond as part of our efforts to support all members of the Israeli pediatric technological community. Our mission is to bring personalized medicine to children through the development of drugs to transform today’s children into tomorrow’s healthy adults.”
Rapid Progress and Pharmaceutical Interest
The development and potential applications of the brain chip technology have garnered significant attention from pharmaceutical companies. According to Tenenbaum, clinical testing of existing drugs for ASD could commence within 18 months. Meanwhile, the process of developing new drugs would naturally require a longer timeframe. Pharma companies have already shown keen interest in the brain chip technology and its potential to revolutionize the field.
Looking ahead, the innovative approach developed by Itay and Beyond offers a promising avenue for advancing the treatment of neurological and psychiatric disorders. As the technology continues to evolve, it has the potential to bring transformative change, improving the lives of millions of people worldwide.
Stay tuned to Discover New Innovations and follow us on social media to keep up with the latest developments in medical research and technology.
What are your thoughts on this groundbreaking research? Share your comments below or subscribe to our newsletter for more fascinating articles like this one. Don’t forget to like and share this post on social media to spread the word!
